56 results on '"Vandrey, Ryan"'
Search Results
2. Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder
3. A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products
4. Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes
5. Real-Time Monitoring of Cannabis and Prescription Opioid Co-Use Patterns, Analgesic Effectiveness, and the Opioid-Sparing Effect of Cannabis in Individuals With Chronic Pain
6. Cannabinoids for Agitation in Alzheimer's Disease
7. Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy
8. Perceived reward from using cigarettes with alcohol or cannabis and concurrent use: A smartphone-based daily diary study
9. Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain
10. Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
11. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
12. Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis
13. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users
14. Measuring the temporal association between cannabis and tobacco use among Co-using young adults using ecological momentary assessment
15. Changing landscape of cannabis: novel products, formulations, and methods of administration
16. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder
17. S140 - I Crave Not to Feel Uncomfortable: Craving for Opioids and Cannabis Among Patients With Chronic Pain
18. S17 - Evaluation of the Pharmacokinetic and Pharmacodynamic Profile of Cannabigerol (CBG) in Human Subjects
19. DOSE EFFECTS OF ORAL AND VAPORIZED DELTA-8-THC AND COMPARISON TO DELTA-9-THC IN HEALTHY ADULTS
20. WITHIN-SUBJECT, DOUBLE-BLIND HUMAN LABORATORY EVALUATION OF CANNABIDIOL ON OPIOID-INDUCED ANALGESIA AND SUBJECTIVE EFFECTS
21. Sleep Management Among Patients with Substance Use Disorders
22. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration
23. Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients
24. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
25. A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users
26. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study
27. Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects
28. Chapter 43 - An overview of current pharmacologic interventions for management of cannabis withdrawal syndrome and the evidence for their use
29. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users
30. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal
31. Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (THC-AD)
32. Comparison of cannabis and tobacco withdrawal: Severity and contribution to relapse
33. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms
34. Contributors
35. Cannabis withdrawal in adolescent treatment seekers
36. Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant users
37. Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use
38. Chapter 88 - Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens
39. Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users
40. TRIAL OF DRONABINOL ADJUNCTIVE TREATMENT OF AGITATION IN ALZHEIMER'S DISEASE (AD) (THC-AD)
41. Web-based treatment for substance use disorders: Differential effects by primary substance
42. Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD
43. 166. Targeting Sleep Disturbance in the Treatment of Cannabis Use Disorders
44. Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence
45. A survey study to characterize use of Spice products (synthetic cannabinoids)
46. Pay-for-performance in a community substance abuse clinic
47. Perceived nicotine content and its association with perceived disease risks of spectrum research cigarettes
48. Attitudes and practices of cannabis dispensary staff
49. 43.2 CANNABIS WITHDRAWAL AND SLEEP DISTURBANCE: IMPLICATIONS FOR THE TREATMENT OF CANNABIS USE DISORDER
50. List of Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.